SHPG : Analysis & Opinions

  1. Merrimack Pharma to Sell Cancer Drugs for $1B

    January 9, 2017
    Merrimack will sell some cancer drugs in a $1 billion deal and will lay off 80% of its workforce.
  2. Most Important Mergers and Acquisitions of 2016

    December 27, 2016
    While 2016 did not see a $100 billion deal, there were plenty of important multibillion-dollar deals.
  3. Merrimack's Cancer Drug Wins EU Nod (MACK, SHPG)

    October 18, 2016
    A pancreatic cancer drug jointly developed by Merrimack Pharmaceuticals and its UK partner, Shire Plc, has been approved ...
  4. Merrimack Pharma's CEO Exits; Layoffs Announced

    October 4, 2016
    A great deal of change is in the air at Merrimack Pharmaceuticals (NASDAQ: MACK), which has announced the departure of its ...
  5. Corporations Have Been Issuing Larger Bonds (BUD, SHPG)

    September 21, 2016
    The issuance of multibillion dollar bonds are becoming a common occurrence in the market.
  6. (ADHD) Who are Alcobra's Main Competitors?

    May 8, 2016
    Learn about Alcobra, a young player in treating attention deficit hyperactiviy disorder (ADHD) that may give its competitors ...
  7. 10 Stocks to Watch Due to a Weaker Euro (JAZZ, FLTX)

    March 9, 2016
    Learn about factors that impact the performance of the euro in 2016 and the top 10 European stocks that will see the greatest ...
  8. Top 5 Positions in John Paulson's Portfolio (AGN, VRX)

    February 29, 2016
    Find out which stocks are holding the top five positions in investment guru John Paulson's hedge fund portfolio and which ...
  9. New Offer for Baxalta

    January 12, 2016
    Shire announced a new offer for Baxalta at $45.6 per share. The deal would be financed by~$21B in equity and ~$16B in cash
  10. Chipotle Suffers From E. Coli Scare (SHPG, DYAX)

    November 2, 2015
    Shares of Mexican fast food chain Chipotle Mexican Grill Inc. are down nearly 6% before the open after the company reported ...